We determined the prevalence of peripheral arterial disease (PAD) and associated risk factors in an urban population age ≥30 years in Turkey and assessed the impact of incorporating ankle brachial index (ABI) measurement with coronary heart disease risk calculations to the risk reclassification of individuals. The sample was drawn from 4600 participants of Balcova Heart Study. The prevalence of low ABI (<0.9) was 6.3%. Current smoking (odds ratio [OR]: 5.07, 95% confidence interval [CI]: 1.85-13.88), cardiovascular disease history (OR: 6.83, 95% CI: 3.00-15.53), hypertension (OR: 2.58, 95% CI: 1.06-6.33), diabetes (OR: 3.25, 95% CI: 1.51-6.98), and high waist circumference (OR: 2.24, 95% CI: 1.02-4.94) were positively associated with prevalent PAD. When ABI measurement was taken into account, 3.5% of low or intermediate risk patients were reclassified as high risk. Screening individuals who have one of these risk factors with ABI can help reclassifying individuals toward the high-risk category.
AkgunSRaoCYardimN. Estimating mortality and causes of death in Turkey: methods, results and policy implications. Eur J Public Health. 2007;17(6):593–599.
2.
LopezADMurrayCC. The global burden of disease, 1990-2020. Nat Med. 1998;4(11):1241–1243.
3.
BartholomewJROlinJW. Pathophysiology of peripheral arterial disease and risk factors for its development. Cleve Clin J Med. 2006;73(suppl 4):S8–S14.
4.
NewmanABSiscovickDSManolioTA. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993;88(3):837–845.
HirschATCriquiMHTreat-JacobsonD. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317–1324.
7.
GreenlandPAbramsJAurigemmaGP. Prevention conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000;101(1):E16–E22.
8.
CookNRRidkerPM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009;150(11):795–802.
9.
FowkesFGMurrayGDButcherI. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197–208.
10.
MeijerWTHoesAWRutgersDBotsMLHofmanAGrobbeeDE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol. 1998;18(2):185–192.
11.
KrogerKStangAKondratievaJ. Prevalence of peripheral arterial disease—results of the Heinz Nixdorf recall study. Eur J Epidemiol. 2006;21(4):279–285.
12.
BozkurtAKTasciITabakOGumusMKaplanY. Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis—CAREFUL study: a national, multi-center, cross-sectional observational study. BMC Cardiovasc Disord. 2011;11:4.
13.
ErgorGSoysalASozmenK. Balcova heart study: rationale and methodology of the Turkish cohort. Int J Public Health. 2012;57(3):535–542.
14.
KhanTHFarooquiFANiaziK. Critical review of the ankle brachial index. Curr Cardiol Rev. 2008;4(2):101–106.
15.
ManciaGDe BackerG, Dominiczak A, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens. 2007;25(9):1751–1762.
16.
NorgrenLHiattWRDormandyJA. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(suppl 1):S1–S75.
17.
Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62–S69.
18.
LeanMEHanTSMorrisonCE. Waist circumference as a measure for indicating need for weight management. BMJ. 1995;311(6998):158–161.
19.
PerryACApplegateEBAllisonMDJacksonMLMillerPC. Clinical predictability of the waist-to-hip ratio in assessment of cardiovascular disease risk factors in overweight, premenopausal women. Am J Clin Nutr.1998;68(5):1022–1027.
20.
Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497.
21.
LamarcheBMoorjaniSLupienPJ. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation. 1996;94(3):273–278.
22.
WilsonPWD'AgostinoRBLevyDBelangerAMSilbershatzHKannelWB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–1847.
23.
SelvinEErlingerTP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110(6):738–743.
24.
EldrupNSillesenHPrescottENordestgaardBG. Ankle brachial index, C-reactive protein, and central augmentation index to identify individuals with severe atherosclerosis. Eur Heart J. 2006;27(3):316–322.
25.
KarabayÖKaracelikMYılıkL. Ischemic peripheral arterial disease: a screening survey. Türk Göğüs Kalp Damar Cerrahisi Dergisi. 2012;20(3):450–457.
26.
BeckmanJACreagerMALibbyP. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–2581.
27.
AllisonMACriquiMHMcClellandRL. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2006;48(6):1190–1197.
28.
CriquiMHVargasVDenenbergJO. Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation. 2005;112(17):2703–2707.
29.
MurabitoJMEvansJCNietoKLarsonMGLevyDWilsonPW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143(6):961–965.
30.
KulloIJBaileyKRKardiaSLMosleyTHJrBoerwinkleETurnerST. Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study. Vasc Med. 2003;8(4):237–242.
31.
Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333–3341.
32.
MeijerWTGrobbeeDEHuninkMGHofmanAHoesAW. Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch Intern Med. 2000;160(19):2934–2938.
33.
DagenaisGRMauriceSRobitailleNMGingrasSLupienPJ. Intermittent claudication in Quebec men from 1974-1986: the Quebec Cardiovascular Study. Clin Invest Med. 1991;14(2):93–100.
34.
IngolfssonIOSigurdssonGSigvaldasonHThorgeirssonGSigfussonN. A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol—the Reykjavik Study. J Clin Epidemiol. 1994;47(11):1237–1243.
35.
CuiRIsoHYamagishiK. Ankle-arm blood pressure index and cardiovascular risk factors in elderly Japanese men. Hypertens Res. 2003;26(5):377–382.
36.
CarbayoJADivisonJAEscribanoJ. Using ankle-brachial index to detect peripheral arterial disease: prevalence and associated risk factors in a random population sample. Nutr Metab Cardiovasc Dis. 2007;17(1):41–49.
37.
ManzanoLGarcia-Diaz J deDGomez-CerezoJ. Clinical value of the ankle-brachial index in patients at risk of cardiovascular disease but without known atherothrombotic disease: VITAMIN study [in Spanish]. Rev Esp Cardiol. 2006;59(7):662–670.
38.
AboyansVCriquiMHDenenbergJOKnokeJDRidkerPMFronekA. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation. 2006;113(22):2623–2629.
39.
AlexanderJK. Obesity and coronary heart disease. Am J Med Sci. 2001;321(4):215–224.
40.
LaneJSVittinghoffELaneKTHiramotoJSMessinaLM. Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002. J Vasc Surg. 2006;44(2):319–324.
41.
IxJHBiggsMLKizerJR. Association of body mass index with peripheral arterial disease in older adults: the Cardiovascular Health Study. Am J Epidemiol. 2011;174(9):1036–1043.
42.
VogtMTCauleyJAKullerLHNevittMC. Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J Bone Miner Res. 1997;12(2):283–289.
43.
van der KliftMPolsHAHakAEWittemanJCHofmanAde LaetCE. Bone mineral density and the risk of peripheral arterial disease: the Rotterdam Study. Calcif Tissue Int. 2002;70(6):443–449.
44.
DobbelsteynCJJoffresMRMacLeanDRFlowerdewG. Acomparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int J Obes Relat Metab Disord. 2001;25(5):652–661.
45.
LuBZhouJWaringMEParkerDREatonCB. Abdominal obesity and peripheral vascular disease in men and women: a comparison of waist-to-thigh ratio and waist circumference as measures of abdominal obesity. Atherosclerosis. 2010;208(1):253–257.
46.
Aydin. Which predicts the cardiovascular risk best in elderly metabolic syndrome patients: ATP III or IDF?Turk J Med Sci. 2011;41(1):125–129.
47.
Baena-DiezJMAlzamoraMTForesRPeraGToranPSorribesM.Ankle-brachial index improves the classification of cardiovascular risk: PERART/ARTPER Study. Rev Esp Cardiol. 2011;64(3):186–192.
48.
RamosRQuesadaMSolanasP. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg. 2009;38(3):305–311.
49.
KorkmazLAdarAErkanH. Ankle-brachial index and coronary artery lesion complexity in patients with acute coronary syndromes. Angiology. 2012;63(7):495–499.
50.
Holland-LetzTEndresHGBiedermannS. Reproducibility and reliability of the ankle-brachial index as assessed by vascular experts, family physicians and nurses. Vasc Med. 2007;12(2):105–112.
51.
ParaskevasKIGiannoukasADMikhailidisDP. The impact of impaired renal function on long-term outcomes in patients with peripheral arterial disease. Angiology. 2010;61(4):415–416.
52.
SheenYJLinJLLeeITHsuYNLiTCSheuWH. Low estimated glomerular filtration rate is a major determinant of low ankle-brachial index and toe-brachial index in type 2 diabetes. Angiology. 2012;63(1):55–61.
